Evidence map›Paper›PMID 37284369›Full record

ArticleCureus2023

Cefiderocol as a Treatment Option for Stenotrophomonas maltophilia Causing Hospital-Acquired/Ventilator-Associated Pneumonia.

Muhammad Humayoun Rashid, Syeda Neelam Yamin Bukhari, Aliaa Mousa, Ahmed Ali Aziz, Knkush Hakobyan

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. ASM case reports · 2025
    Article
  2. Cefiderocol treatment for patients infected by Stenotrophomonas maltophilia, Burkholderia cepacia complex and Achromobacter spp.: subgroup analysis from the PERSEUS study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Observational
  3. Antimicrobial susceptibility ofAntimicrobial agents and chemotherapy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Muhammad Humayoun RashidInternal Medicine, Capital Health Regional Medical Center, Trenton, USA.
Syeda Neelam Yamin BukhariInternal Medicine, Nishtar Medical University, Multan, PAK.
Aliaa MousaInternal Medicine, Capital Health Regional Medical Center, Trenton, USA.
Ahmed Ali AzizInternal Medicine, Capital Health Regional Medical Center, Trenton, USA.
Knkush HakobyanInternal Medicine, Capital Health Regional Medical Center, Trenton, USA.
Regional Medical Center · USCapital Health · USNishtar Medical College and Hospital · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant (MDR) gram-negative bacteria have been causing havoc for the healthcare system because of the rarity of the treatment options available.

Indexed as

cefiderocolhospital-acquired pneumoniamulti-drug resistant bacteriastenotophomonas maltophiliaventilator-associated pneumonia

Identifiers

PMID37284369
PMCPMC10239792
OpenAlexW4372404123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.